1. Home
  2. AMBO vs CDIO Comparison

AMBO vs CDIO Comparison

Compare AMBO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$1.98

Market Cap

6.5M

Sector

Real Estate

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$1.56

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
CDIO
Founded
2000
2017
Country
United States
United States
Employees
N/A
17
Industry
Other Consumer Services
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
5.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AMBO
CDIO
Price
$1.98
$1.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.7K
24.3K
Earning Date
08-05-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
N/A
EPS
0.01
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
$171,906.75
Revenue Next Year
N/A
N/A
P/E Ratio
$286.49
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.97
52 Week High
$6.75
$7.91

Technical Indicators

Market Signals
Indicator
AMBO
CDIO
Relative Strength Index (RSI) 38.35 37.80
Support Level $2.01 $1.22
Resistance Level $2.55 $2.28
Average True Range (ATR) 0.12 0.12
MACD -0.01 -0.01
Stochastic Oscillator 45.24 36.90

Price Performance

Historical Comparison
AMBO
CDIO

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: